Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000903423-17-000463
Filing Date
2017-07-11
Accepted
2017-07-11 16:26:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 glaxo-alleron13da_0711.htm SC 13D/A 19777
2 glaxo-alleron13daex2_0711.htm EX-2 30047
  Complete submission text file 0000903423-17-000463.txt   51321
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Subject) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90032 | Film No.: 17960251
SIC: 2834 Pharmaceutical Preparations